Platelets and fibrinolysis.

Area of Science:

• Biomedical Science
• Hematology
• Pharmacology

Background:

• Thrombolytic therapy is increasingly used but faces challenges like lysis delay, reocclusion, and hemorrhage.
• Platelets play a dual role in thrombosis and fibrinolysis, significantly influencing thrombolytic therapy success.

Purpose of the Study:

• To review the complex molecular mechanisms underlying platelet activation and inhibition during thrombolysis.
• To elucidate the role of platelets in thrombolytic therapy's efficacy and safety.

Main Methods:

• Literature review focusing on platelet function and molecular events during thrombolysis.
• Analysis of studies investigating platelet-rich versus platelet-poor thrombi sensitivity to lysis.

Main Results:

• Platelet-rich thrombi are less responsive to thrombolysis and more prone to reocclusion.
• Platelet activation initially retards lysis, while prolonged exposure leads to inhibition and increased hemorrhage risk.

Conclusions:

• Platelet behavior during thrombolysis is complex and directly affects treatment outcomes.
• Further research into platelet molecular events is crucial for optimizing thrombolytic strategies and mitigating adverse effects.